Luke Smith represents companies across the nation in complex litigation and antitrust compliance. He provides antitrust counseling and analysis in proposed mergers and acquisitions, including Hart-Scott Rodino Act (HSR) pre-merger filing notifications. Other clients, primarily healthcare companies, have benefited from Luke’s knowledge of industry-specific antitrust issues, including clinical integration, accountable care organizations, payor/provider negotiations, and healthcare joint ventures. During the past five years, Luke has advised on transactions worth more than $12 billion, two thirds of which were in the healthcare industry.
American Bar Association, Antitrust Section
American Health Law Association (AHLA)
Representation of J. Alexander’s Holdings, Inc. (NYSE: JAX), owner and operator of J. Alexander’s Restaurant, Redlands Grill, Stoney River Steakhouse and Grill and selected other restaurants, in its $220 million all cash sale to SPB Hospitality LLC, a leading operator and franchisor of full-service dining restaurants.
Since J. Alexander’s first opened in 1991, Bass, Berry & Sims has served as primary corporate and securities counsel to the company for more than 30 years. Additional details about the transaction can be found in the official news release.
We represented Helix Sleep, Inc. (Helix) in its sale to Cerberus Capital Management, L.P. (Cerberus), a global leader in alternative investing.
Representation of Addus HomeCare Corporation (NASDAQ: ADUS) in its $29.1 million acquisition of three affiliated entities: Armada Skilled Home Care of New Mexico, LLC, Armada Hospice of New Mexico, LLC and Armada Hospice of Santa Fe, LLC. This acquisition expands Addus HomeCare’s home health and hospice services in the state of New Mexico.
Representation of Brookdale Senior Living Inc. (NYSE: BKD) in its definitive agreement to sell 80 percent of Brookdale Health Care Services, the Brentwood-based company’s home health and outpatient therapy division, to HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, in an all-cash transaction for $400 million
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.
Representation of the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible for the operational and strategic management of Chartwell to CarepathRx, a platform company formed by Nautic Partners that offers pharmacy solutions to patients undergoing complicated medication therapies. Nautic will manage the UPMC pharmacy moving forward. Terms of the transaction were not disclosed.
Representation of Mississippi Sports Medicine and Orthopaedic Center, PLLC, a leading orthopedic care provider in Mississippi, in its sale to FFL Partners, a San Francisco-based private equity firm. With this acquisition, FFL Partners formed a new orthopedic health services organization, U.S. Orthopedic Partners.
Vanderbilt Law Review